Innovative UNC-based Public-Private HIV Investigative Group Secures $20m & Continues its Leading ‘Induce & Reduce’ Strategy

University of North Carolina (UNC) Chapel Hill researchers and local industry scientists secured $20 million in the from of a research contract targeting a cure for HIV. The deal was executed between ViiV Healthcare and UNC at Chapel Hill to renew the unique,...

Cancer Immunotherapy Likely Safe for those with Chronic Infections Reports Georgetown University Retrospective Study

A retrospective study driven by Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, found that cancer patients battling viral infections such as HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) shouldn’t be precluded from immune...

Pin It on Pinterest